Skip to main content
Erschienen in: Breast Cancer 4/2020

01.02.2020 | Original Article

Could ductoscopy alleviate the need of microdochectomy in pathological nipple discharge?

verfasst von: Yuk-Kwan Chang, Clement Tzu-Hsin Chen, Min Wang, Yong Yang, Bonita Mark, Ai-qiu Zheng, Ava Kwong

Erschienen in: Breast Cancer | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Microdochectomy is the gold-standard for definitive diagnosis for pathological nipple discharge (PND); however, problem of over-treating exists since majority of PND are self-limiting and due to benign causes. Ductoscopy may assist diagnosis, and triage patients for intervention or expectant management. This study aimed to evaluate if ductoscopy could reduce unnecessary microdochectomy but not compromising the diagnosis of malignancy.

Method

A multicenter, retrospective study was conducted in consecutive patients of PND without a suspected malignancy on routine diagnostic evaluation. Ductoscopy was performed with attempts to remove intraductal lesions if they were found. Microdochectomy was carried out if there were positive intraductal lesions, but failed endoscopic extraction, or failed ductoscopy and persistent PND. Efficacy of ductoscopy was determined by cannulation success rate, number of avoided surgery and number of missed malignancy.

Results

In a 3-year period between 2016 and 2018, a total of 223 ductoscopy were performed and 94.2% had successful cannulation. Within such, 59.5% (N = 125) had intraductal mass identified, and 82 microdochectomy were carried out. The final histology showed 15 malignancy, making the overall malignancy rate 6.7%. Ductoscopy successful and negative patients (N = 85, 37.8%) were triaged for surveillance and the malignancy rate is 0% in a median follow-up of 2 years; hence, microdochectomy was avoided.

Conclusion

PND with non-suspicious conventional imaging and negative ductoscopy have rare malignancy rate which makes subsequent microdochectomy unnecessary. However, intraductal mass in ductoscopy is a predictor for malignancy so definitive histology diagnosis is mandatory.
Literatur
1.
Zurück zum Zitat Seltzer MH. Breast complaints, biopsies, and cancer correlated with age in 10,000 consecutive new surgical referrals. Breast J. 2004;10(2):111–7.CrossRef Seltzer MH. Breast complaints, biopsies, and cancer correlated with age in 10,000 consecutive new surgical referrals. Breast J. 2004;10(2):111–7.CrossRef
2.
Zurück zum Zitat Lau S, Kuchenmeister I, Stachs A, Gerber B, Krause A, Reimer T. Pathologic nipple discharge: surgery is imperative in postmenopausal women. Ann Surg Oncol. 2005;12(7):546–51.CrossRef Lau S, Kuchenmeister I, Stachs A, Gerber B, Krause A, Reimer T. Pathologic nipple discharge: surgery is imperative in postmenopausal women. Ann Surg Oncol. 2005;12(7):546–51.CrossRef
3.
Zurück zum Zitat Dolan RT, Butler JS, Kell MR, Gorey TF, Stokes MA. Nipple discharge and the efficacy of duct cytology in evaluating breast cancer risk. Surgeon. 2010;8(5):252–8.CrossRef Dolan RT, Butler JS, Kell MR, Gorey TF, Stokes MA. Nipple discharge and the efficacy of duct cytology in evaluating breast cancer risk. Surgeon. 2010;8(5):252–8.CrossRef
4.
Zurück zum Zitat Istomin A, Masarwah A, Pitkanen M, Joukainen S, Sutela A, Vanninen R, et al. Galactography is not an obsolete investigation in the evaluation of pathological nipple discharge. PLoS ONE. 2018;13(10):e0204326.CrossRef Istomin A, Masarwah A, Pitkanen M, Joukainen S, Sutela A, Vanninen R, et al. Galactography is not an obsolete investigation in the evaluation of pathological nipple discharge. PLoS ONE. 2018;13(10):e0204326.CrossRef
5.
Zurück zum Zitat Baydoun S, Gonzalez P, Whitman GJ, Dryden M, Xi Y, Dogan B. Is Ductography still warranted in the 21st century? Breast J. 2019;25(4):654–62.CrossRef Baydoun S, Gonzalez P, Whitman GJ, Dryden M, Xi Y, Dogan B. Is Ductography still warranted in the 21st century? Breast J. 2019;25(4):654–62.CrossRef
6.
Zurück zum Zitat Lustig DB, Warburton R, Dingee CK, Kuusk U, Pao JS, McKevitt EC. Is microductectomy still necessary to diagnose breast cancer: a 10-year study on the effectiveness of duct excision and galactography. Breast Cancer Res Treat. 2019;174(3):703–9.CrossRef Lustig DB, Warburton R, Dingee CK, Kuusk U, Pao JS, McKevitt EC. Is microductectomy still necessary to diagnose breast cancer: a 10-year study on the effectiveness of duct excision and galactography. Breast Cancer Res Treat. 2019;174(3):703–9.CrossRef
7.
Zurück zum Zitat Morrogh M, Morris EA, Liberman L, Borgen PI, King TA. The predictive value of ductography and magnetic resonance imaging in the management of nipple discharge. Ann Surg Oncol. 2007;14(12):3369–77.CrossRef Morrogh M, Morris EA, Liberman L, Borgen PI, King TA. The predictive value of ductography and magnetic resonance imaging in the management of nipple discharge. Ann Surg Oncol. 2007;14(12):3369–77.CrossRef
8.
Zurück zum Zitat van Gelder L, Bisschops RH, Menke-Pluymers MB, Westenend PJ, Plaisier PW. Magnetic resonance imaging in patients with unilateral bloody nipple discharge; useful when conventional diagnostics are negative? World J Surg. 2015;39(1):184–6.CrossRef van Gelder L, Bisschops RH, Menke-Pluymers MB, Westenend PJ, Plaisier PW. Magnetic resonance imaging in patients with unilateral bloody nipple discharge; useful when conventional diagnostics are negative? World J Surg. 2015;39(1):184–6.CrossRef
9.
Zurück zum Zitat Wang LJ, Wu P, Li XX, Luo R, Wang DB, Guan WB. Magnetic resonance imaging features for differentiating breast papilloma with high-risk or malignant lesions from benign papilloma: a retrospective study on 158 patients. World J Surg Oncol. 2018;16(1):234.CrossRef Wang LJ, Wu P, Li XX, Luo R, Wang DB, Guan WB. Magnetic resonance imaging features for differentiating breast papilloma with high-risk or malignant lesions from benign papilloma: a retrospective study on 158 patients. World J Surg Oncol. 2018;16(1):234.CrossRef
10.
Zurück zum Zitat Simmons R, Adamovich T, Brennan M, Christos P, Schultz M, Eisen C, et al. Nonsurgical evaluation of pathologic nipple discharge. Ann Surg Oncol. 2003;10(2):113–6.CrossRef Simmons R, Adamovich T, Brennan M, Christos P, Schultz M, Eisen C, et al. Nonsurgical evaluation of pathologic nipple discharge. Ann Surg Oncol. 2003;10(2):113–6.CrossRef
11.
Zurück zum Zitat Lesetedi C, Rayne S, Kruger D, Benn CA. Indicators of breast cancer in patients undergoing microdochectomy for a pathological nipple discharge in a middle-income country. J Surg Res. 2017;220:336–40.CrossRef Lesetedi C, Rayne S, Kruger D, Benn CA. Indicators of breast cancer in patients undergoing microdochectomy for a pathological nipple discharge in a middle-income country. J Surg Res. 2017;220:336–40.CrossRef
12.
Zurück zum Zitat Galvin R, Joyce D, Downey E, Boland F, Fahey T, Hill AK. Development and validation of a clinical prediction rule to identify suspected breast cancer: a prospective cohort study. BMC Cancer. 2014;14:743.CrossRef Galvin R, Joyce D, Downey E, Boland F, Fahey T, Hill AK. Development and validation of a clinical prediction rule to identify suspected breast cancer: a prospective cohort study. BMC Cancer. 2014;14:743.CrossRef
13.
Zurück zum Zitat Vargas HI, Vargas MP, Eldrageely K, Gonzalez KD, Khalkhali I. Outcomes of clinical and surgical assessment of women with pathological nipple discharge. Am Surg. 2006;72(2):124–8.PubMed Vargas HI, Vargas MP, Eldrageely K, Gonzalez KD, Khalkhali I. Outcomes of clinical and surgical assessment of women with pathological nipple discharge. Am Surg. 2006;72(2):124–8.PubMed
14.
Zurück zum Zitat Waaijer L, Simons JM, Borel Rinkes IH, van Diest PJ, Verkooijen HM, Witkamp AJ. Systematic review and meta-analysis of the diagnostic accuracy of ductoscopy in patients with pathological nipple discharge. Br J Surg. 2016;103(6):632–43.CrossRef Waaijer L, Simons JM, Borel Rinkes IH, van Diest PJ, Verkooijen HM, Witkamp AJ. Systematic review and meta-analysis of the diagnostic accuracy of ductoscopy in patients with pathological nipple discharge. Br J Surg. 2016;103(6):632–43.CrossRef
15.
Zurück zum Zitat Kamali S, Bender O, Aydin MT, Yuney E, Kamali G. Ductoscopy in the evaluation and management of nipple discharge. Ann Surg Oncol. 2010;17(3):778–83.CrossRef Kamali S, Bender O, Aydin MT, Yuney E, Kamali G. Ductoscopy in the evaluation and management of nipple discharge. Ann Surg Oncol. 2010;17(3):778–83.CrossRef
16.
Zurück zum Zitat Waaijer L, van Diest PJ, Verkooijen HM, Dijkstra NE, van der Pol CC, Borel Rinkes IH, et al. Interventional ductoscopy in patients with pathological nipple discharge. Br J Surg. 2015;102(13):1639–48.CrossRef Waaijer L, van Diest PJ, Verkooijen HM, Dijkstra NE, van der Pol CC, Borel Rinkes IH, et al. Interventional ductoscopy in patients with pathological nipple discharge. Br J Surg. 2015;102(13):1639–48.CrossRef
17.
Zurück zum Zitat Balci FL, Feldman SM. Interventional ductoscopy for pathological nipple discharge. Ann Surg Oncol. 2013;20(10):3352–4.CrossRef Balci FL, Feldman SM. Interventional ductoscopy for pathological nipple discharge. Ann Surg Oncol. 2013;20(10):3352–4.CrossRef
18.
Zurück zum Zitat Liu M, Guo G, Xie F, Wang S, Yang H. Mammary ductoscopy and follow-up avoid unnecessary duct excision in patients with pathologic nipple discharge. J Surg Oncol. 2015;112(2):139–43.CrossRef Liu M, Guo G, Xie F, Wang S, Yang H. Mammary ductoscopy and follow-up avoid unnecessary duct excision in patients with pathologic nipple discharge. J Surg Oncol. 2015;112(2):139–43.CrossRef
19.
Zurück zum Zitat Makita M, Akiyama F, Gomi N, Iwase T. Mammary ductoscopy and watchful follow-up substitute microdochectomy in patients with bloody nipple discharge. Breast Cancer. 2016;23(2):242–51.CrossRef Makita M, Akiyama F, Gomi N, Iwase T. Mammary ductoscopy and watchful follow-up substitute microdochectomy in patients with bloody nipple discharge. Breast Cancer. 2016;23(2):242–51.CrossRef
20.
Zurück zum Zitat Makita M, Akiyama F, Gomi N, Iwase T, Kasumi F, Sakamoto G. Endoscopic and histologic findings of intraductal lesions presenting with nipple discharge. Breast J. 2006;12(5 Suppl 2):S210–S217217.CrossRef Makita M, Akiyama F, Gomi N, Iwase T, Kasumi F, Sakamoto G. Endoscopic and histologic findings of intraductal lesions presenting with nipple discharge. Breast J. 2006;12(5 Suppl 2):S210–S217217.CrossRef
21.
Zurück zum Zitat Denewer A, El-Etribi K, Nada N, El-Metwally M. The role and limitations of mammary ductoscope in management of pathologic nipple discharge. Breast J. 2008;14(5):442–9.CrossRef Denewer A, El-Etribi K, Nada N, El-Metwally M. The role and limitations of mammary ductoscope in management of pathologic nipple discharge. Breast J. 2008;14(5):442–9.CrossRef
22.
Zurück zum Zitat Han Y, Li J, Han S, Jia S, Zhang Y, Zhang W. Diagnostic value of endoscopic appearance during ductoscopy in patients with pathological nipple discharge. BMC Cancer. 2017;17(1):300.CrossRef Han Y, Li J, Han S, Jia S, Zhang Y, Zhang W. Diagnostic value of endoscopic appearance during ductoscopy in patients with pathological nipple discharge. BMC Cancer. 2017;17(1):300.CrossRef
23.
Zurück zum Zitat Rose C, Bojahr B, Grunwald S, Frese H, Jager B, Ohlinger R. Ductoscopy-based descriptors of intraductal lesions and their histopathologic correlates. Onkologie. 2010;33(6):307–12.CrossRef Rose C, Bojahr B, Grunwald S, Frese H, Jager B, Ohlinger R. Ductoscopy-based descriptors of intraductal lesions and their histopathologic correlates. Onkologie. 2010;33(6):307–12.CrossRef
24.
Zurück zum Zitat Yamamoto D, Tsubota Y, Yoshida H, Kanematsu S, Sueoka N, Uemura Y, et al. Endoscopic appearance and clinicopathological character of breast cancer. Anticancer Res. 2011;31(10):3517–20.PubMed Yamamoto D, Tsubota Y, Yoshida H, Kanematsu S, Sueoka N, Uemura Y, et al. Endoscopic appearance and clinicopathological character of breast cancer. Anticancer Res. 2011;31(10):3517–20.PubMed
25.
Zurück zum Zitat Louie LD, Crowe JP, Dawson AE, Lee KB, Baynes DL, Dowdy T, et al. Identification of breast cancer in patients with pathologic nipple discharge: does ductoscopy predict malignancy? Am J Surg. 2006;192(4):530–3.CrossRef Louie LD, Crowe JP, Dawson AE, Lee KB, Baynes DL, Dowdy T, et al. Identification of breast cancer in patients with pathologic nipple discharge: does ductoscopy predict malignancy? Am J Surg. 2006;192(4):530–3.CrossRef
26.
Zurück zum Zitat Dietz JR, Crowe JP, Grundfest S, Arrigain S, Kim JA. Directed duct excision by using mammary ductoscopy in patients with pathologic nipple discharge. Surgery. 2002;132(4):582–7.CrossRef Dietz JR, Crowe JP, Grundfest S, Arrigain S, Kim JA. Directed duct excision by using mammary ductoscopy in patients with pathologic nipple discharge. Surgery. 2002;132(4):582–7.CrossRef
27.
Zurück zum Zitat Kamali S, Bender O, Kamali GH, Aydin MT, Karatepe O, Yuney E. Diagnostic and therapeutic value of ductoscopy in nipple discharge and intraductal proliferations compared with standard methods. Breast Cancer. 2014;21(2):154–61.CrossRef Kamali S, Bender O, Kamali GH, Aydin MT, Karatepe O, Yuney E. Diagnostic and therapeutic value of ductoscopy in nipple discharge and intraductal proliferations compared with standard methods. Breast Cancer. 2014;21(2):154–61.CrossRef
28.
Zurück zum Zitat Simpson JS, Connolly EM, Leong WL, Escallon J, McCready D, Reedijk M, et al. Mammary ductoscopy in the evaluation and treatment of pathologic nipple discharge: a Canadian experience. Can J Surg. 2009;52(6):E245–E248248.PubMedPubMedCentral Simpson JS, Connolly EM, Leong WL, Escallon J, McCready D, Reedijk M, et al. Mammary ductoscopy in the evaluation and treatment of pathologic nipple discharge: a Canadian experience. Can J Surg. 2009;52(6):E245–E248248.PubMedPubMedCentral
29.
Zurück zum Zitat Zervoudis S, Tamer V, Iatrakis G, Bothou A, Tokou X, Augoulea A, et al. Improving ductoscopy with duct lavage and duct brushing. Eur J Gynaecol Oncol. 2014;35(5):548–53.PubMed Zervoudis S, Tamer V, Iatrakis G, Bothou A, Tokou X, Augoulea A, et al. Improving ductoscopy with duct lavage and duct brushing. Eur J Gynaecol Oncol. 2014;35(5):548–53.PubMed
Metadaten
Titel
Could ductoscopy alleviate the need of microdochectomy in pathological nipple discharge?
verfasst von
Yuk-Kwan Chang
Clement Tzu-Hsin Chen
Min Wang
Yong Yang
Bonita Mark
Ai-qiu Zheng
Ava Kwong
Publikationsdatum
01.02.2020
Verlag
Springer Japan
Erschienen in
Breast Cancer / Ausgabe 4/2020
Print ISSN: 1340-6868
Elektronische ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-020-01051-w

Weitere Artikel der Ausgabe 4/2020

Breast Cancer 4/2020 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.